Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

10.1007/BF00201968

10.1016/0002-9343(88)90356-7

10.1016/S0140-6736(89)90430-3

10.1084/jem.170.3.865

10.1016/S0065-2776(08)60642-2

Miossec P, 1987, The role of interleukin 1 in the pathogenesis of rheumatoid arthritis., Clin Exp Rheumatol, 5, 305

10.1172/JCI112350

10.1002/eji.1830140603

10.1083/jcb.106.2.311

10.1126/science.2783498

10.1016/S0174-173X(85)80033-9

10.1002/anr.1780320210

10.1172/JCI113823

10.1016/S0174-173X(82)80007-1

10.1016/0014-5793(86)80406-9

10.1002/anr.1780320310

10.1073/pnas.83.22.8749

Stimpson SA, 1988, Exacerbation of arthritis by IL‐1 in rat joints previously injured by peptidoglycan‐polysaccharide., J Immunol, 140, 2964, 10.4049/jimmunol.140.9.2964

Hom JT, 1988, In vivo administration with IL‐1 accelerates the development of collageninduced arthritis in mice., J Immunol, 141, 834, 10.4049/jimmunol.141.3.834

Jacobs C, 1988, In vivo treatment with IL‐1 reduces the severity and duration of antigen‐induced arthritis in rats., J Immunol, 141, 2967, 10.4049/jimmunol.141.9.2967

Wallach D, 1988, Sensitization and desensitization to lethal effects of tumor necrosis factor and IL‐1., J Immunol, 140, 2994, 10.4049/jimmunol.140.9.2994

Henderson B, 1988, Production of interleukin 1 in the joint during the development of antigen‐induced arthritis in the rabbit., Clin Exp Immunol, 74, 371

Hopkins SJ, 1988, Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL‐1., Clin Exp Immunol, 72, 422

Yamagata N, 1988, Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis., J Rheumatol, 15, 1623

10.1016/0008-8749(88)90332-2

10.1002/art.1780310404

Buchan G, 1988, Interleukin‐1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL‐1α., Clin Exp Immunol, 73, 449

Firestein GS, 1989, Quantitative analysis of cytokine gene expression in rheumatoid arthritis (abstract)., Clin Res, 37, 586A

10.1016/S0140-6736(88)90185-7

Shore A, 1986, Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis., Clin Exp Immunol, 65, 293

Dayer J‐M, 1989, Inflammation and Disease.

Arend WP, 1989, An interleukin 1 inhibitor from human monocytes: production and characterization of biological properties., J Immunol, 143, 1851, 10.4049/jimmunol.143.6.1851

10.1016/0167-5699(89)90308-3

Arend WP, 1985, Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor., J Immunol, 134, 3868, 10.4049/jimmunol.134.6.3868

10.1172/JCI112669

Seckinger P, 1987, A urine inhibitor of interleukin 1 activity affects both interleukin 1α and 1β but not tumor necrosis factor α., J Immunol, 139, 1541, 10.4049/jimmunol.139.5.1541

Seckinger P, 1987, A urine inhibitor of interleukin 1 activity that blocks ligand binding., J Immunol, 139, 1546, 10.4049/jimmunol.139.5.1546

10.1016/1043-4666(89)91047-8

Lotz M, 1989, Transforming growth factor β and cellular immune responses in synovial fluids (abstract)., Arthritis Rheum, 32, S42

10.1172/JCI112631

Roux‐Lombard P, 1988, Inhibitors of IL‐1 and TNFα activities in synovial fluids and cultured synovial fluid cell supernatants (abstract)., Calcif Tissue Int, 42, S(A47)

10.1016/S0140-6736(87)91854-X

10.1083/jcb.107.4.1269

10.1084/jem.162.6.2163

Henderson B, 1989, Arthritogenic actions of recombinant IL‐1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between eytokines in vivo., Clin Exp Immunol, 75, 306

10.1016/0008-8749(89)90154-8

Hopkins SJ, 1988, Cytokines in synovial fluid. II. The presence of tumour necrosis factor and interferon., Clin Exp Immunol, 73, 88

10.1002/art.1780310816

10.1016/0896-8411(88)90006-6

10.1084/jem.167.4.1511

Seckinger P, 1989, Purification and biologic characterization of a specific tumor necrosis factor α inhibitor., J Biol Chem, 264, 11966, 10.1016/S0021-9258(18)80161-2

Engelmann H, 1989, A tumor necrosis factor‐binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity., J Biol Chem, 264, 11974, 10.1016/S0021-9258(18)80162-4

10.1111/j.1600-0609.1989.tb00111.x

10.1084/jem.170.4.1409

10.1016/0167-5699(88)91200-5

10.1172/JCI113921

10.1002/art.1780310614

10.1002/eji.1830181122

Bhardwaj N, 1989, IL‐6/IFN‐β2 in synovial effusions of patients with rheumatoid arthritis and other arthritides: identification of several isoforms and studies of cellular sources., J Immunol, 143, 2153, 10.4049/jimmunol.143.7.2153

10.1016/0090-1229(89)90175-X

10.1172/JCI113111

10.1002/art.1780300804

10.1084/jem.168.5.1573

10.1172/JCI113971

Williamson DJ, 1988, The detection and initial characterization of colonystimulating factors in synovial fluid., Clin Exp Immunol, 72, 67

10.3181/00379727-186-3-RC2

Lafyatis R, 1988, Demonstration of local production of PDGF and TGF‐β by synovial tissue from patients with rheumatoid arthritis (abstract)., Arthritis Rheum, 31, S62

Butler DM, 1989, Stimulation of human synovial fibroblast DNA synthesis by plateletderived growth factor and fibroblast growth factor., J Immunol, 142, 3098, 10.4049/jimmunol.142.9.3098

10.1172/JCI114011

Kumkumian GK, 1989, Platelet‐derived growth factor and IL‐1 interactions in rheumatoid arthritis: regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription., J Immunol, 143, 833, 10.4049/jimmunol.143.3.833

10.1083/jcb.105.3.1039

Czarniecki CW, 1988, Transforming growth factor‐β modulates the expression of class II histocompatibility antigens on human cells., J Immunol, 140, 4217, 10.4049/jimmunol.140.12.4217

10.1084/jem.169.1.291

Lafyatis R, 1989, Transforming growth factor‐β production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats: studies on secretion by synovial fibroblast‐like cells and immunohistologic localization., J Immunol, 143, 1142, 10.4049/jimmunol.143.4.1142

10.1084/jem.168.4.1403